R-554

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameR-554
Drug Alias NameR-554
ClassificationSmall molecules
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsReperfusion InjuryBrain InjuriesAcute Lung Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRadikal Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesRadikal Therapeutics
Inactive CompaniesN/A
Active IndicationsReperfusion InjuryBrain InjuriesAcute Lung Injury
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A